(Q64723944)
Statements
An Open-Label Extension to the Double-Blind SP513 Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Subjects With Early-Stage Idiopathic Parkinson's Disease (English)
0 references
August 2002
0 references
December 2008
0 references
381
0 references
30 year
0 references